Tumour expressions of hypoxic markers predict the response to neo-adjuvant chemotherapy in children with inoperable rhabdomyosarcoma. [electronic resource]
Producer: 20191230Description: 538-548 p. digitalISSN:- 1366-5804
- Adolescent
- Antigens, Neoplasm -- genetics
- Biomarkers, Tumor -- genetics
- Biopsy
- Carbonic Anhydrase IX -- genetics
- Carboplatin -- therapeutic use
- Chemotherapy, Adjuvant -- methods
- Child
- Child, Preschool
- Dactinomycin -- therapeutic use
- Epirubicin -- therapeutic use
- Female
- Gene Expression
- Glucose Transporter Type 1 -- genetics
- Humans
- Hypoxia -- diagnosis
- Hypoxia-Inducible Factor 1, alpha Subunit -- genetics
- Ifosfamide -- therapeutic use
- Infant
- Infant, Newborn
- Male
- Muscle Neoplasms -- diagnosis
- Neoadjuvant Therapy -- methods
- Prognosis
- Prospective Studies
- Rhabdomyosarcoma, Alveolar -- diagnosis
- Rhabdomyosarcoma, Embryonal -- diagnosis
- Survival Analysis
- Treatment Outcome
- Vascular Endothelial Growth Factor A -- genetics
- Vincristine -- therapeutic use
No physical items for this record
Publication Type: Journal Article
There are no comments on this title.
Log in to your account to post a comment.